Clinical trial · Observational
The Association Between Blood Routine Parameters and Breast Cancer Prognosis
The Association Between Blood Routine Parameters Combined With Clinicopathological Characteristics and Breast Cancer Prognosis: a Real-world Study
NCT07584213CI-TRIAL-00111461active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a real-world multicentre study to investigate the association between blood routine parameters combined with clinicopathological characteristics and breast cancer prognosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Invasive | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood routine test | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Blood routine test
- description
- breast cancer patients with baseline blood routine results available
- interventionNames
- Procedure: blood routine test
Primary outcomes (1)
- measure
- Disease-free survival
- timeFrame
- From the date of radical surgery until time of event up to 3 years
- description
- Disease-free survival time is defined as the time from the date of radical surgery until the date of the first occurrence of local/regional relapse, distant recurrence, contralateral breast cancer, second malignancy and death from any cause.
Secondary outcomes (2)
- measure
- Recurrence-free survival
- timeFrame
- From the date of radical surgery until time of event up to 3 years
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 18 years or older * Pathologically confirmed invasive primary breast cancer Exclusion Criteria: * De novo stage IV breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.